by rss feed | Feb 24, 2026 | iPS cell therapies, IPS cells, Japan, Japan Regenerative Medicine, News Feeds
A Japanese panel voted to move 2 iPS cell therapies forward for approval despite there being minimal clinical trial data. Let's discuss the context and potential risks. The post Japan panel OK’s 2 iPS cell therapies despite little data appeared first on The...
